Target intelligence / Profile preview

Tectonic family member 3 (TCTN3)

Target
TCTN3
Molecular classification
Other (Single-pass membrane protein, part of the tectonic family, associated with the ciliary transition zone)
01

Overview

Tectonic family member 3 (TCTN3) is a single-pass membrane protein localized at the ciliary transition zone, where it is an essential component of protein complexes involved in tissue-specific ciliogenesis and the regulation of ciliary membrane composition. It is required for proper Sonic Hedgehog (SHH) signal transduction and plays a critical role in neural tube development. Mutations in TCTN3 are linked to human ciliopathies including orofaciodigital syndrome IV and Joubert syndrome 18, leading to a wide range of developmental defects such as craniofacial abnormalities, brain anomalies, congenital heart disease, and neural tube defects. Loss of TCTN3 disrupts SHH signaling and may also interfere with apoptosis regulation via the PI3K/Akt pathway. No direct evidence is available to indicate TCTN3 is a current therapeutic drug target, nor are there known drugs that target it.

Other names
C10orf61Tectonic-3TECT3PSEC0041UNQ1881/PRO4324DKFZP564D116JBTS18OFD4
02

Biological functions

Hedgehog signal transductionNeural tube developmentRegulation of apoptosisTissue-specific ciliogenesis and ciliary membrane composition
03

Disease associations

Ciliopathies (broadly)Orofaciodigital syndrome IV (OFD4)Joubert syndrome 18 (JBTS18)Neural tube defectsCongenital heart disease
04

Safety considerations

Mutations result in severe developmental disorders including orofaciodigital syndromes, neural tube defects, and potentially lethal prenatal phenotypes in animal models

Beyond the preview

Go deeper on Tectonic family member 3 (TCTN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tectonic family member 3 (TCTN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call